I know this has become a little on the controversial side but I have done a little research and this is what I have found. Celvapan is the name of the H1N1 vaccine and from the European Medicines Agency it says this:
"Which measures are being taken to ensure the safe use of Celvapan?
The company that makes Celvapan will collect information on the safety of the vaccine while it is being used. This will include information on its side effects and its safety in children, the elderly, pregnant women, patients with severe conditions and people who have problems with their immune systems."
The company that makes it "will collect information on the safety of the vaccine while it is being used"?
Go here and read the EPAR For the Public for yourselves. EPAR Summary For the Public
3 hours ago